Abstract
Cocaine is a naturally occurring alkaloid extracted from the leaves of the South American shrub Erythroxylon coca. Early European explorers reported the habit of chewing of coca leaves by native populations, and systematic investigations of the effects of cocaine were conducted in the late nineteenth century by Sigmund Freud and others. For a review of the older literature on cocaine, the reader is referred to VanDyke and Byck (1974). Cocaine possesses short-acting local anesthetic and vasoconstrictor properties, which make it clinically useful for topical application. Its actions as a local anesthetic are due to inhibition of neuronal sodium channels which results in blockage of the initiation and conduction of nerve impulses. This area is not discussed in detail in this chapter. Cocaine is a Schedule II drug in the United States. Its abuse is associated with enormous costs to both addicted individuals and to society as a whole. Valuable perspectives on the abuse of cocaine and other stimulants were provided by Gawin and Ellinwood (1988).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ackerman, J. M., & White, F. J. (1990). A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neuroscience Letters, 117, 181–187.
Akimoto, K., Hamamura, T., & Otsuki, S. (1989). Sub-chronic cocaine treatment enhances cocaine induced dopamine efflux, studied by in vivo intracerebral dialysis. Brain Research, 490, 339–344.
Ambre, J. (1985). The urinary excretion of cocaine and metabolites in humans: A kinetic analysis of published data. Journal ofAnalytic Toxicology. 9, 241–245.
Balster, R. L., & Schuster, C. R. (1973). Fixed-interval schedule of cocaine reinforcement: Effect of dose and infusion duration. Journal of Experimental and Analytic Behavior, 20, 119–129.
Barnet, G., Hawks, R., & Resnick, R. (1981). Cocaine pharmacokinetics in humans. Journal of Ethnopharmacology, 3, 353–366.
Berger, S. P., Hall, S., Mickalian, J. D., Reid, M. S., Crawford, C. A., Delucchi, K., Carr, K., & Hall, S. (1996). Haloperidol antagonism of cue-elicited cocaine craving. Lancet, 347, 504–508.
Biegon, A., Dillon, K., Volkow, N. D., Hitzemann, R. J., Fowler, J. S., Wolf, A. P. (1992). Quantitative autoradiography of cocaine binding sites in human brain postmortem. Synapse, 10, 126–130.
Boja, J. W, Carroll, F. I., Rahman, M. A., Philip, A., Lewin, A. H., & Kuhar, M. J. (1990). New, potent cocaine analogs: Ligand binding and transport studies in rat striatum. European Journal of Pharmacology, 184, 329–332.
Boja, J. W, Patel, A., Carroll, F. I., Rahman, M. A., Philip, A., Lewin, A., Kopajtic, T. A., & Kuhar, M. J. (1991). [’251]RTI-55: A potent ligand for dopamine transporters. European Journal of Pharmacology, 194, 133–134.
Boja, J. W, Markham, L., Patel, A., Uhl, G., Kuhar, M. J. (1992). Expression of a single dopamine transporter cDNA can confer two cocaine binding sites. Neuroreport, 3, 247–248.
Braestrup, C. (1977). Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats. Journal of Pharmacy and Pharmacology, 26, 463–470.
Brzezinski, M. R., Abraham, T. R., Stone, C. L., Dean, R. A., & Bosron, W F. (1994). Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochemical Pharmacology, 48, 1747–1755.
Butcher, S., Liptrot, J., & Aburthnot, G. (1991). Characterization of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neuroscience Letters, 122, 245–248.
Calligaro, D. O., & Eldefrawi, M. E. (1988). High affinity stereospecific binding of [3H]cocaine in striatum and its relationship to the dopamine transporter. Membrane Biochemistry, 7, 87–106.
Carelli, R. M., King, V C., Hampson, R. E., & Deadwyler, S. A. (1993). Firing patterns of nucleus accumbens neurons during cocaine self-administration in rats. Brain Research, 626, 14–22.
Carlezon, W. A., Devine, D. P., & Wise, R. A. (1995). Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacologv. 122, 194–197.
Carroll, F. 1., Lewin, A. H., Boja, J. W., & Kuhar, M. J. (1992). Cocaine receptor: Biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. Journal of Medicinal Chemistry, 35, 969–981.
Carroll, E I., Kotian, P., Dehghani, A., Gray, J. L., Kuzemko, M. A., Parham, K. A., Abraham, P., Lewin, A. H., Boja, J. W., & Kuhar, M. J. (1995). Cocaine and 3b-(4’-substituted phenyl)tropane-2b-carboxylic acid ester and amide analogues: New high-affinity and selective compounds for the dopamine transporter. Journal of Medicinal Chemistry, 38, 379–388.
Cass, W. A., & Zahniser, N. R. (1993). Cocaine levels in striatum and nucleus accumbens: Augmentation following challenge injection in rats withdrawn from repeated cocaine administration. Neuroscience Letters, 152, 177–180.
Chait, L. D., Uhlenhuth, E. H., & Johanson, C. E. (1987). Reinforcing and subjective effects of several anorectics in normal human volunteers. Journal of Pharmacology and Experimental Therapeutics, 242, 777–783.
Chiueh, C. C., & Kopin, I. J. (1978). Endogenous epinephrine and norepinephrine from the synpathoadrenal medullary system of unanesthetized rats. Journal of Pharmacology and Experimental Therapeutics, 205, 14–154.
Chow, M. J., Ambre, J. J., Ruo, T. 1., Atkinson, A. J., Bowsher, D. J., & Fischman, M. W. (1985). Kinetics of cocaine distribution, elimination and chronotropic effects. Clinical Pharmacology Therapy, 38, 318–324.
Clarke, R. L., Daum, S. J., Gambino, A. J., Aceto, M. D., Pearl, J., Levitt, M., Cumisky, W. R., & Bogado, E. E. (1973). Compounds affecting the central nervous system 4 3-b-phenyltropane-2-carboxylic esters and analogs. Journal of Medicinal Chemistry, 16, 1260–1267.
Cone, E. J. (1995). Pharmacokinetics and pharmacodynamics of cocaine. Journal of Analytic Toxicology, 19, 459–478.
Cone, E. J., Kumor, K., Thompson, L. K., & Sherer, M. (1988). Correlation of saliva cocaine levels with plasma levels and with pharmacological effects after intravenous cocaine administration in human subjects. Journal of Analytic Toxicology, 12, 200–206.
Connell, P. H. (1958) Amphetamine psychosis. London: Chapman and Hill.
Cook, C. E., Jeffcoat, A. R., & Perez-Reyes, M. (1985) Pharmacokinetic studies of cocaine and phencyclidine in man. In G. Barnett & N. C. Chang (Eds.), Pharmacokinetics and pharmacodynamies of psychoactive drugs (pp. 48–74 ). Foster City, CA: Biomedical Publications.
Dackis, C. A., & Gold, M. S. (1985). New concepts in cocaine addiction: The dopamine depletion hypothesis. Neuroscience and Behavior Review, 9, 469–477.
Davies, H. M. L., Saikali, E., Sexton, T., & Childers, S. R. (1993). Novel 2-substituted cocaine analogs-bindingproperties at dopamine transport sites in rat striatum. European Journal of Pharmacology, 244, 93–97.
Dean, R. A., Christian, C. D., Sample, R. H. B., & Bosron, W. F. (1991). Human liver cocaine esterases: Ethanol mediated formation of ethylcocaine. Federation of the American Societies for Experimental Biology Journal, 5, 2735–2739.
Dean, R. A., Bosron, W. F., Zachman, F. M., Zhang, J., & Brzezinski, M. R. (1997). Effects of ethanol on cocaine metabolism and disposition in the rat. NIDA Research Monograph No. 173, pp. 35–47 ). Washington, DC: U.S. Government Printing Office.
Deutsch, H. M., & Schweri, M. M. (1994). Can stimulant binding and dopamine transport be differentiated-studies with GBR-12783 derivatives. Life Science, 55, 1115–1120.
Deutsch, H. M., Shi, Q., Gruszecka-Kowalik, E., & Schweri, M. M. (1996). Synthesis and pharmacology of potential cocaine antagonists: 2. Structure-activity relationship studies of aromatic ring substituted methylphenidate analogs. Journal of Medicinal Chemistry, 39, 1201–1209.
deWit, H., Metz, J. T., Wagner, N., & Cooper, M. D. (1990). Behavioral and subjective effects of alcohol: Relationship to cerebral metabolism using PET. Alcoholism: Clinical and Experimental Research, 14, 482–489.
deWit, H., Metz, J. T., & Cooper, M. D. (1994) The effects of drugs of abuse on regional cerebral metabolism and mood. In B. N. Dhawan, R. C. Srimal, R. Raghubir, & R. S. Rapaka (Eds.), Recent advances in the study of neurotransmitter receptors (pp. 482–489 ). Lucknow, India: Central Drug Research Institute.
Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Science, 85, 5274–5278.
Einhorn, L. C., Johansen, P. A., & White, F. J. (1988). Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Studies in the ventral tegmental area. Journal of Neuroscience, 8, 100–112.
El-Fawal, H. A. N., & Wood, R. W. (1995). airway smooth muscle relaxant effects of the cocaine pyrolysis product, methylecgonidine. Journal of Pharmacology and Experimental Therapeutics, 272, 991–996.
Erzouki, H. K., Allen, A. C., Newman, A. H., Goldberg, S. R., & Schindler, C. W. (1995). Effects of cocaine, cocaine metabolites and cocaine pyrolysis products on the hindbrain cardiorespiratory centers of the rabbit. Life Science, 57, 1861–1868.
Eshleman, E. J., Henningsen, R. A., Neve, K. A., & Janowsky, A. (1994). Release of dopamine via the human transporter. Molecular Pharmacology, 45, 312–316.
Evans, S. M., Cone, E. J., Marco, A. P., & Henningfield, J. E. (1992) A comparison of the kinetics of smoked and intravenous cocaine. In L. Harris (Ed.), Problems of drug dependence (p. 343 ). Rockville, MD: U.S. Department of Health and Human Services.
Farre, M., Torre, R. D. L., Llorente, M., Lamas, X., Ugena, B., Segura, J., & Cami, J. (1993). Alcohol and cocaine interactions in humans. Journal of Pharmacology and Experimental Therapeutics, 266, 1364–1373.
Fitzgerald, J. L., & Reid, J. J. (1991). Chronic cocaine treatment does not alter rat striatal D2 autoreceptor sensitivity to pergolide. Brain Research, 541, 327–333.
Foltin, R. W, & Fischman, M. W. (1992). Self-administration of cocaine by humans: Choice between smoked and intravenous cocaine,. Journal of Pharmacology and Experimental Therapeutics. 261, 841–849.
Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., & MacGregor, R. R. (1989). Mapping cocaine binding sites in human and baboon brain in vivo. Synapse, 4, 371–377.
Fowler, J. S., Volkow, N. D., Logan, J., MacGregor, R. R., Wang, G. J., & Wolf, A. P. (1992). Alcohol intoxication does not change [I IC] cocaine pharmacokinetics in human brain and heart. Synapse, 12, 228–135.
Fowler, J. S., Volkow, N. D., MacGregor, R. R., Logan, J., Dewey, S. L., Gatley, S. J., & Wolf, A. P. (1992). Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene baboon brain. Synapse, 12, 220–227.
Fowler, J. S., Ding, Y.-S., Volkow, N. D., Martin, T., MacGregor, R. R., Dewey, S., King, P., Pappas, N., Alexoff, D., Shea, C., Gatley, S. J., Schlyer, D. J., & Wolf, A. P. (1994). PET studies of cocaine inhibition of the my- ocardial norepinephrine uptake. Synapse, 16, 312–317.
Frost, J. J., Rosier, A. J., Reich, S. G., Smith, J. S., Ehlers, M. D., Snyder, S. H., Ravert, H. T., & Dannals, R. F. (1993). Positron emission tomographic imaging of the dopamine transporter with “C-WIN 35,428 reveals marked declines in mild Parkinson’s disease. Annals of Neurology, 34, 423–431.
Galloway, M. P. (1988). Neurochemical interactions of cocaine with the dopaminergic system. Trends in Pharmacological Science, 9, 451–454.
Gardner, E. L. (1992). Brain reward mechanisms. In J. H. Lowinson, P. Ruiz, J. G. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (pp. 70–99 ). Baltimore, MD: Williams and Wilkins.
Garrett, E. R., & Seyda, K. (1983). Prediction of stability in pharmaceutical preparations XX: Stability, evaluation and bioanalysis of cocaine and benzoylecgonine by high performance liquid chromatography. Journal of Pharmacy and Science, 72, 258–271.
Gatley, S. J. (1991). The activities of the enantiomers of cocaine, and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase. Biochemical Pharmacology, 41, 1249–1254.
Gatley, S. J., MacGregor, R. R., Fowler, J. S., Wolf, A. P., Dewey, S. L., & Schlyer, D. J. (1990). Rapid stereos-elective hydrolysis of (+) cocaine in baboon plasma prevents its uptake in the brain: Implications for behavioral studies. Journal of Neurochemistry, 54, 720–723.
Gatley, S. J., Yu, D.-W., Fowler, J. S., MacGregor, R. R., Schlyer, D. J., Dewey, S. L., Wolf, A. P., Shea, C. E., Martin, T. E, & Volkow, N. D. (1994). Studies with differentially labeled C-11 cocaine, C-1 I nor-cocaine, C-11 benzoylecgonine, and C-11 and F-18 4’-fluorococaine, to probe the extent to which C-Il cocaine metabolites contribute to PET images of the baboon brain. Journal of Neurochemistry, 62, 1154–1162.
Gatley, S. J., Pan, D., Chen, R., Chatrurvedi, G., & Ding, Y.-S. (1996). Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Science, 58, PL231–PL239.
Gatley, S. J., Volkow, N. D., Chen, R., Fowler, J. S., Carroll, F. I., & Kuhar, M. J. (1996). Displacement of rti55 from the dopamine transporter by cocaine: implications for pharmacotherapy of stimulant abuse and in vivo imaging studies. European Journal of Pharmacology, 296, 145–151.
Gawin, F. H., & Ellinwood, E. H. (1988). Cocaine and other stimulants. New England Journal of Medicine, 318, 1173–1182.
Gawin, F. H., Riordan, C., & Kleber, H. D. (1985). Methylphenidate use in non-ADD cocaine abusers: A negative study. American Journal of Drug and Alcohol Abuse, 11, 193–197.
Gifford, A. N., & Johnson, K. M. (1992). Comparison of the role of local anaesthetic properties with dopamine uptake blockade in the inhibition of striatal and nucleus accumbens [3H]acetylcholine release by cocaine. Journal of Pharmacology and Experimental Therapeutics, 263, 757–761.
Gifford, A. N., Bergmann, J. S., & Johnson, K. M. (1993). GBR 12909 fails to antagonize cocaine induced elevation of dopamine in striatal slices. Drug and Alcohol Dependence, 93, 65–71.
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606–612.
Gradman, A. H. (1988). Cardiac effects of cocaine: A review. Yale Journal of Biological Medicine, 61, 137–141.
Guerin, G. F., Goeders, N. E., Dworkin, S. I., & Smith, J. E. (1984). Intracranial self-administration of dopamine into the nucleus accumbens. Society of Neuroscience Abstracts, 10, 1072.
Hawks, R. L., Kopin, I. J., Colburn, R. W., & Thoa, N. B. (1975). Norcocaine: A pharmacologically active metabolite of cocaine found in brain. Life Science, 15, 2189–2195.
He, X. S., Raymon, L. P., Mattson, M. V, Eldefrawi, M. E., & DeCosta, B. R. (1993). Further studies of the structure-activity relationships of I-[I-(2benzo[b]thienyl)cyclohexyl]piperidine. synthesis and evaluation of I-(2-benzo[b]thienyl)-N,N-dialkylcyclohexylamines at dopamine uptake and phencyclidine binding sites. Journal of Medicinal Chemistry, 36, 4075–4081.
Hearn, W. L., Flynn, D. D., Hime, G. W., Rose, S., Confino, J. C., ManteroAtienza, E., Wetli, C. W, & Mash, D. C. (1991). Cocaethylene: A unique cocaine metabolite displays high-affinity for the dopamine. transporter. Journal of Neurochemistry, 56, 698–701.
Henningfield, J. E., & Keenan, R. M. (1993). Nicotine delivery kinetics and abuse liability. Journal of Consulting and Clinical Psychiatry, 61, 743–750.
Henry, D. J., & White, F. J. (1991). Repeated cocaine administration caused persistent enhancement of DI dopamine receptor sensitivity within the rat nucleus accumbens. Journal of Pharmacology and Experimental Therapeutics, 258, 882–890.
Henry, D. J., Greene, M. A., & White, E J. (1989). Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Repeated administration. Journal of Experimental Therapeutics, 251, 833–839.
Hoffman, D. C., & Wise, R. A. (1993). Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin. Psychopharmacology, 110, 402–408.
Huester, D. C. (1987). Cardiovascular effects of cocaine. Journal of the American Medical Association, 257, 979–980.
Hurd, Y. L., & Herkenham, M. (1993). Molecular alterations in the neostriatum of human cocaine addicts. Synapse, 13, 357–369.
Hurd, Y. L., & Ungerstedt, U. (1989). Cocaine: An in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse, 3, 48–54.
Inaba, T. (1989). Cocaine: Pharmacokinetics and biotransformation in man. Canadian Journal of Physiology and Pharmacology, 67, 1154–1157.
Isner, J., Estes, M., & Thompson, P. D. (1986). Acute cardiac events temporally related to cocaine abuse. New England Journal of Medicine, 15, 1438–1443.
lyer, R. N., Nobiletti, J. B., Jatlow, P. I., & Bradberry, C. W. (1995). cocaine and cocaethylene: Effects on extracellular dopamine in the primate. Psychopharmacology, 120, 150–155.
Izenwasser, S., & Cox, B. M. (1990). Daily cocaine treatment produces a persistent reduction in [3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Research, 531, 338–341.
Jaffe, J. H. (1990). Trivializing dependence. British Journal of Addiction, 85, 1425–1427.
Javaid, J. I., Musa, M. N., Fischman, M., Schuster, C. R., & Davis, J. M. (1983). Kinetics of cocaine in humans after intravenous and intranasal administration. Biopharmacology of Drug Disposition, 4, 9–18.
Jeffcoat, A. R., Perez-Reyes, M., Hill, J. M., Sadler, B. M., & Cook, C. E. (1989). Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metabolism and Disposition, 17, 153–159.
Johanson, C.-E., & Fischman, M. W. (1989). The pharmacology of cocaine related to its abuse. Pharmacological Review 41, 3–52.
Johanson, C.-E., & Schuster, C. R. (1995) Cocaine. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 1685–1697 ). New York: Raven.
Johnson, K. M., Bergmann, J. S., & Kozikowski, A. P. (1992). Cocaine and dopamine differentially protect [3H]mazindol binding sites from alkylation by N-ethylmaleimide. European Journal of Pharmacology, 227, 411–427.
Kalivas, P. W., & Alesdatter, J. E. (1993). Involvement of NMDA receptor stimulation in the VTA and amygdala in behavioral sensitization to cocaine. Journal of Pharmacology and Experimental Therapeutics, 267, 486–495.
Kalivas, P. W., & Weber, B. (1988). Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. Journal of Pharmacology and Experimental Therapeutics, 245, 1095–1101.
Karler, R., Calder, L. D., Chaudhry, I. A., & Turkanis, S. A. (1989). Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801. Life Science, 45, 599–606.
Karler, R., Calder, L. D., & Bedingfield, J. B. (1994). Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology, 115, 305–310.
Kaufman, M. J., Spealman, R. D., & Madras, B. K. (1991). Distribution of cocaine recognition sites in monkey brain. In vitro autoradiography with [3H]CFT. Synapse, 9, 177–187.
Kennedy, L. T., & Hanbauer, I. (1983). Sodium sensitive cocaine binding to rat striatal membrane: Possible relationship to dopamine uptake. Journal of Neurochemistry, 41, 172–178.
Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D. M., & Uhl, G. R. (1992). Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proceedings of the National Academy of Science, 89, 7782–7785.
Kleber, H. D. (1995). Pharmacotherapy, current and potential, for the treatment of cocaine dependence. Clinical Neuropharmacology, 18 (Suppl. 1), S96-S 109.
Kloner, R. A., Hale, S., Alker, K., & Rezkalla, S. (1992). The effects of acute and chronic cocaine use on the heart. Circulation, 85, 407–419.
Kosikowski, A. P., Salah, M. K. E., Johnson, K. M., & Bergmann, J. M. (1995). Chemistry and biology of the 23-alkyl-33-phenyl analogues of cocaine: Subnanomolar affinity ligands that suggest a new pharmacophore at the C-2 position. Journal of Medicinal Chemistry, 38, 3086–3093.
Lakoski, J. M., & Cunningham, K. A. (1988). Cocaine interaction with central monoaminergic systems: Electrophysiological approaches. Trends in Pharmacological Science, 9, 177–180.
Laruelle, M., Baldwin, R. M., Malison, R. T., Zea-Ponce, Y., Zoghbi, S. S., Al-Tikriti, M., Sybirska, E. H., Zimmermann, R. C., Wisniewski, G., Neumeyer, J. L., Milius, R. A., Wang, R. A., Smith, E. O., Roth, R. H., Charney, D., Hoffer, P. B., & Innis, R. B. (1993). SPECT imaging of dopamine and serotonin transporters with [I-123] beta-CIT: Pharmacological characterization of brain uptake in non-human primates. Synapse, 13, 295–309.
Levin, S. R., & Welch, K. M. A. (1988). Cocaine and stroke: Current concepts of cerebrovascular disease. Stroke, 19, 779–7883.
Lichtenfeld, P. J., Rubin, D. B., & Feldman, R. S. (1984). Subarachnoid hemorrhage precipitated by cocaine snorting. Archives of Neurology, 41, 223–224.
Lienau, A. K., & Kuschinsky, K. (1997). Sensitization phenomena after repeated administration of cocaine or D-amphetamine in rats: Associative and non-associative mechanisms and the role of dopamine in the striatum. Naunyn Schmiedehergs Archives of Pharmacology, 355, 531–537.
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendirem, B., Gatley, S. J., & Christman, D. R. (1990). Graphical analysis of reversible radiolig and binding from time activity measurements applied to [N-“ C-methyl]-(-)cocaine PET studies in human subjects. Journal of Cerebral Blood Flow and Metabolism, 10, 740–747.
London, E. D., Cascella, N. G., Wong, D. F., Phillips, R. L., Dannals, R. F., Links, J. M., Herning, R., Grayson, R., Jaffe, J. H., & Wagner, H. N. J. (1990). Cocaine-induced reduction of glucose utilization in human brain: A study using positron emission tomography and [Fluorine 18]-Fluorodeoxyglucose. Archives of General Psychiatry, 47, 567–574.
Madden, J. A., & Powers, R. H. (1990). Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sciences, 47, 1109–1114.
Madras, B. K. (1994). “C-WIN 35,428 for detecting dopamine depletion in mild Parkinson’s disease. Annals of Neurology, 35, 376–377.
Madras, B. K., & Kaufman, M. J. (1994). Cocaine accumulates in dopamine rich regions of primate brain after I.V. administration: Comparison with mazindol distribution. Synapse, 18, 261–275.
Madras, B. K., Fahey, M. A., Bergman, J., Canfield, D. R., & Spealman, R. D. (1989). Effects of cocaine and related drugs in non-human primates. I [3H]Cocaine binding sites in caudate-putamen. Journal of Pharmacology and Experimental Therapeutics, 251, 131–141.
Madras, B. K., Spealman, R. D., Fahey, M. A., Neumeyer, J. L., Saha, J. K., & Milius, R. A. (1989). Cocaine receptors labeled by [3H]2b-carbomethoxy-3b-(4fluorophenyl)tropane. Molecular Pharmacology, 36, 518–524.
Masserano, J. M., Venable, D., & Wyatt, R. J. (1994). Effect of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats. Journal of Pharmacology and Experimental Therapeutics, 270, 133–141.
Mattingly, B. A., Hart, T. C., Lim, K., & Perkins, C. (1994). Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacolog. 114, 239–242.
McElvain, J. S., & Schenk, J. O. (1992). A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochemical Pharmacology, 43, 2189–2199.
Meehan, S. M., & Schechter, M. D. (1995). Cocaethyleneinduced lethality in mice is potentiated by alcohol. Alcohol, 12, 383–385.
Meltzer, P. C., Liang, A. Y., Brownell, A. L., Elmaleh, D. R., & Madras, B. K. (1993). Substituted 3-phenyltropane analogs of cocaine: Synthesis and inhibition of binding at cocaine recognition sites, and positron emission tomography imaging. Journal of Medicinal Chemistry, 36, 855–862.
Meltzer, P. C., Liang, A. Y., & Madras, B. K. (1994). The discovery of an unusually selective and novel cocaine analog: Difluoropine (0–620). synthesis and inhibition of binding at cocaine recognition sites. Journal of Medicinal Chemistry, 37, 2001–2010.
Mule, S. J., Casella, G. A., & Misra, A. L. (1976). Intracellular disposition of [3H]cocaine, [3H]norcocaine, [3H]benzoylecgonine and [3H]benzoylnorecgonine in the brain of rats. Life Sciences, 19, 1585–1596.
Nayak, P. K., Misra, A. L., & Mulé, S. J. (1976). Physiological disposition and biotransformation of [3H]cocaine in acutely and chronically treated rats. Journal of Pharmacology and Experimental Therapeutics, 196, 556–569.
Nicolaysen, L. C., Pan, H. T., & Justice, J. B., Jr. (1988). Extracellular cocaine and dopamine concentrations are linearly related in rat striatum. Brain Research, 456, 317–323.
Parran, T. V, & Jasinski, D. R. (1991). Intravenous methylphenidate abuse: Prototype for prescription drug abuse. Archives of Internal Medicine, 151, 781–783.
Parsons, L. H., & Justice, J. B. (1994). Quantitative approaches to in vivo brain microdialysis. Critical Review of Neurobiology 8, 189–220.
Perez-Reyes, M., & Jeffcoat, A. R. (1992). Ethanol/cocaine interaction: Cocaine and cocaethylene plasma concentrations and their relationship to subjective and cardiovascular effects. Life Sciences, 51, 553–563.
Peterson, K. I., Logan, B. K., & Christian, G. D. (1995). Detection of cocaine and its polar transformation products and metabolites in human urine. Forensic Science International, 73, 183–196.
Pettit, H. O., & Justice, J. B., Jr. (1989). Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacology, Biochemistry and Behavior, 34, 899–904.
Pettit, H. O., Pan, H.-T., Parsons, L. H., & Justice, J. B. (1990). Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. Journal of Neurochemistry, 55, 798–804.
Pitts, D. K., & Marwah, J. (1987). Electrophysiological actions of cocaine on noradrenergic neurons in rat locus ceruleus. Journal of Pharmacology and Experimental Therapeutics, 240, 345–351.
Porrino, L. J. (1993). Functional consequences of acute cocaine treatment depend on route of administration. Psychopharmacology, 112, 343–351.
Post, R. M. (1975). Cocaine psychoses: A continuum model. American Journal of Psychiatry, 132, 225–231.
Post, R. M., & Rose, H. (1976). Increasing effects of repetitive cocaine administration in the rat. Nature, 260, 731–732.
Preston, K. L., Sullivan, J. T., Berger, P., & Bigelow, G. E. (1993). Effects of cocaine alone and in combination with mazindol in human cocaine abusers. Journal of Pharmacology and Experimental Therapeutics, 258, 296–307.
Pristupa, Z. B., Wilson, J. M., Hoffman, B. J., Kish, S. J., & Niznik, H. B. (1994). Pharmacological heterogeneity of the cloned and native human dopamine transporter: Disassociation of the [3H]WIN 35,428 and [3H]GBR 12,935 binding. Molecular Pharmacology 45, 125–135.
Przywara, D. A., & Dambach, G. E. (1989). Direct actions of cocaine on cardiac cellular activity. Circulation Research, 65, 185–192.
Qiao, J.-T, Dougherty, P. M., Wiggins, R. C., & Dafny, N. (1990). Effects of microiontophoretic application of cocaine, alone and with receptor antagonists, upon the neurons of the medial prefrontal cortex, nucleus accumbens and caudate nucleus of rats. Neuropharmacology, 29, 379–385.
Rall, T. W. (1993) Hypnotics and sedatives: Ethanol. In A. Goodman-Gilman, L. S. Goodman, T. W Rall, & F. Murad (Eds.), Goodman and Gilman’s the pharmacological basis of therapeutics (pp. 345–382 ). New York: Macmillan.
Rao, A. N., Polos, P. G., & Walther, F. A. (1990). Crack abuse and asthma: A fatal combination. New York State Journal of Medicine, 90, 511–512.
Rech, R. H., Vomachka, M. K., Rickert, D., & Braude, M. C. (1976). Interactions between amphetamine and alcohol, and their effects on rodent behavior. Annals of the New York Academy of Science, 281, 426–440.
Reith, M. E. A., Benuck, M., & Lajtha, A. (1987). Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. Journal of Pharmacology and Experimental Therapeutics, 243, 281–287.
Reith, M. E. A., DeCosta, B., Rice, K. C., & Jacobson, A. E. (1992). Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935 and dopamine to the dopamine transporter. European Journal of Pharmacology, 227, 417–425.
Reith, M. E. A., Coffey, L. L., Xu, C., & Chen, N. H. (1994). GBR 12909 and GBR 12935 block dopamine uptake into brain synaptic vesicles as well as nerve endings. European Journal of Pharmacology, 253, 175–178.
Ritchie, J. M., & Greene, N. M. (1993). Local anesthetics. In A. Goodman-Gilman, T. N. Rall, A. S. Nies, & P. Taylor (Eds.), Goodman and Gilman’s the pharmacological basis of therapeutics ( 8th ed., pp. 311–331 ). New York: Macmillan.
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987). Cocaine receptors on dopamine transporters are related to self administration of cocaine. Science, 237, 1219–1223.
Ritz, M. C., Cone, E. J., & Kuhar, M. J. (1990). Cocaine inhibition of ligand binding at dopamine norepinephrine and serotonin transporters: A structure-activity study. Life Sciences, 46, 635–645.
Roth, L., Harbison, R. B., James, R. C., Tobin, T., & Roberts, S. M. (1992). Cocaine hepatotoxicity: Influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology, 15, 934–940.
Rothman, R. B. (1990). High affinity dopamine reuptake inhibitors as potential cocaine antagonists: A strategy for drug development. Life Sciences, 46, PLI7–PL21.
Rothman, R. B., Mele, A., Reid, A. A., Hyacinth, C. A., Greg, N., Thurkauf, A., DeCosta, B. R., Rice, K. C., & Pert, A. (1991). GBR 12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacology, Biochemistry and Behavior, 40, 387–397.
Rothman, R. B., Grieg, N., Kim, A., De Costa, B. R., Rice, K. C., Carroll, E, & Pert, A. (1992). Cocaine and GBR 12909 produce equivalent motoric responses at different occupancy of the dopamine transporter. Pharmacology, Biochemistry and Behavior, 43, 1135–42.
Rothman, R. B., Becketts, K. M., Radesca, L. R., DeCosta, B. R., Rice, K. C., Carroll, F. I., & Dersch, C. M. (1993). Studies of the biogenic amine transporters: II. A brief study on the use of [3H]DAuptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists. Life Sciences, 53, PL267–PL272.
Seeman, P. (1993). Receptor tables. Volume 2: Drug dissociation constants for neuroreceptors and transporters. Toronto, Ontario, Canada: SZ Resarch.
Seidman, M. H., Lau, C. E., Chen, R., & Falk, J. L. (1992). Orally self-administered cocaine: Reinforcing efficacy by the place preference method. Pharmacology, Biochemistry and Behavior, 43, 235–241.
Self, D. W, & Nestler, E. J. (1995). Molecular mechanisms of drug reinforcement and addiction. Annual Review of Neuroscience, 43, 463–495.
Sharkey, J., Glen, K. A., Wolfe, S., & Kuhar, M. J. (1988). Cocaine binding at sigma receptors. European Journal of Pharmacology, 149, 171–174.
Sharkey, J., Ritz, M. C., Schenden, J. A., Hanson, R. C., & Kuhar, M. J. (1988). Cocaine inhibits muscarinic cholinergic receptors in heart and brain. Journal of Pharmacology and Experimental Therapeutics, 246, 1048–1052.
Sharpe, L. G., Pilotte, N. S., Mitchell, W. M., & DeSouza, E. B. (1991). Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol labelling of dopamine transporter in rat nucleus accumbens. European Journal of Pharmacology, 203, 141–144.
Shuster, L., Yu, G., & Bates, A. (1977). Sensitization to cocaine stimulation in mice. Psychopharmacologv, 52, 185–190.
Simoni, D., Stoelwinder, J., Kozikowski, A. P., Johnson, K. M., Bergmann, J. S., & Ball, R. G. (1993). Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: Discovery of a weak cocaine “antagonist.” Journal of Medicinal Chemistry, 36, 3975–3977.
Sisti, N. J., Fowler, F. W, & Fowler, J. S. (1989). The flash vacuum thermolysis of (-)-cocaine. Tetrahedron Letters, 30, 5977–5980.
Snyder, W. S., Cook, M. J., Nasset, E. S., Karhausen, L. R., Parry-Howells, G., & Tipton, I. H. (1975). Report on the task group on Reference Man (ICRP Publication 23 ). Oxford, England: Pergamon.
Sorg, B. A., & Ulibarri, C. (1995). Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine. Synapse, 20, 217–224.
Spealman, R. D., Goldberg, S. R., Kelleher, R. T., Morse, W. H., Goldberg, D. M., Hakansson, C. G., Nieforth, K. A., & Lazer, E. S. (1979). Effects of norcocaine and some norcocaine derivatives on schedule-controlled behavior of pigeons and squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 210, 196–205.
Spealman, R. D., Kelleher, R. T., & Goldberg, S. R. (1983). Stereoselective effects of cocaine and a phenyltropane analog. Journal of Pharmacology and Experimental Therapeutics, 225, 509–514.
Staley, J. K., Hearn, W. L., Ruttenber, A. J., Wetli, C. V, & Mash, D. C. (1994). High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. Journal of Pharmacology and Experimental Therapeutics, 271, 1678–1685.
Stein, E. A., & Fuller, S. A. (1993). Cocaine time action profile on regional cerebral blood flow in the rat. Brain Research, 626, 117–126.
Stewart, D. J., Inaba, T., Tang, B. K., & Kalow, W. (1977). Hydrolysis of cocaine in human plasma by cholinesterase. Life Sciences, 20, 1557–1564.
Stewart, D. J., Inaba, T., Lucassen, M., & Kalow, W. (1979). Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterases. Clinical Pharmacology and Therapeutics, 25, 464–468.
Stine, S. M., Krystal, J. H., Kosten, T. R., & Charney, D. S. (1995). Mazindol treatment for cocaine dependence. Drug and Alcohol Dependence, 39, 245–253.
Strickland, T. L., Mena, I., Villanueva-Meyer, J., Miller, B. L., Cummings, J., Mehringer, C. M., Satz, P., Myers, H. (1993). Cerebral perfusion and neuropsychological consequences of chronic cocaine use. Journal of Neuropsvchiatry, 5, 1–9.
Tella, S. R., & Goldberg, S. R. (1993). Monoamine uptake inhibitors alter cocaine pharmacokinetics. Psychopharmacology, 112, 497–502.
Tumeh, S., Nagel, J. S., & English, R. J. (1990). Cerebral abnormalities in cocaine abusers: Demonstration by SPECT perfusion brain scintigraphy. Radiology, 176, 821–24.
Turkanis, S. A., Partlow, L. M., & Karler, R. (1989). Effects of cocaine on neuromuscular transmission in the lobster. Neuropharmacology, 18, 971–975.
Uchimura, N., & North, R. A. (1990). Actions of cocaine on rat nucleus accumbens neurones in vitro. British Journal of Pharmacology, 99, 736–740.
Ujike, H., Akiyama, K., & Otsuki, S. (1990). D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology, 102, 459–464.
Van Dyke, C., & Byck, R. (1974) Cocaine: 1884–1974. In E. H. Elinwood (Ed.), Advances in behavioral biology (pp. 1–30 ). New York: Plenum.
Van Dyke, C., Jatlow, P., lingerer, J., Barash, P. G., & Byck, R. (1978). Oral cocaine: Plasma concentrations and central effects. Science, 200, 211–213.
Vezina, E, & Stewart, J. (1989). The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Research, 499, 108–120.
Volkow, N. D., Mullani, N., Gould, K. L., Adler, S., & Krajewski, K. (1988). Cerebral blood flow in chronic cocaine users: A study with positron emission tomography. British Journal of Psychiatry, 152, 641–648.
Volkow, N. D., Hitzemann, R., Wolf, A. P., Logan, J., Fowler, J., Christman, D., Dewey, S., Schlyer, D., Burr, G., Vitkun, S., & Hirschowitz, J. (1990). Acute effects of ethanol on regional brain glucose metabolism and transport. Psychiatry Research, 35, 39–48.
Volkow, N. D., Fowler, J. S., Wolf, A. P., Hitzemann, R., Dewey, S. L., Bendriem, B., Alpert, R., & Hoff, A. (1991). Changes in brain glucose metabolism in cocaine dependence and withdrawal. American Journal of Psychiatry, 148, 621–626.
Volkow, N. D., Gillespie, H., Mullani, N., Tancredi, L., Grant, C., lvanovic, M., & Hollister, L. (1991). Cerebellar metabolic activation by delta-9-tetrahydrocannabinol in human brains: A study with positron emission tomography and 1“F-2-deoxy-2-fluoro-Dglucose. Psychiatric Research, 40, 69–80.
Volkow, N. D., Fowler, J. S., Wolf, A. P., Wang, G.-J., Logan, J., MacGregor, R. R., Dewey, S. L., Schlyer, D. J., & Hitzemann, R. (1992). Distribution and kinetics of carbon-I I-cocaine in the human body measured with PET. Journal of Nuclear Medicine, 33, 521–525.
Volkow, N. D., Hitzemann, R., Wang, G.-J., Fowler, J. S., Wolf, A. P., Dewey, S. L., Burr, G., Piscani, K., Handlesman, L., & Hoff, A. (1992). Long term frontal brain metabolic changes in cocaine abusers. Synapse, 11, 184–190.
Volkow, N. D., Fowler, J. S., Wang, G.-J., Hitzemann, R., Wolf, A. P., Logan, J., Schlyer, D., MacGregor, R. R., Angrist, B., Liebermann, J., Burr, G., & Pappas, N. (1993). PET studies of the function of the dopamine transporter in cocaine abusers. Journal of Nuclear Medicine, 34, 67.
Volkow, N. D., Ding, Y.-S., Fowler, J. S., Wang, G.-J., Logan, J., Gatley, S. J., Dewey, S., Ashby, C., Lieber-mann, J., Hitzemann, R., & Wolf, A. P. (1995). Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Archives of General Psychiatry, 52, 456–463.
Volkow, N. D., Fowler, J. S., Logan, J., Gatley, S. J., Dewey, S. L., MacGregor, R. R., Schlyer, D. J., Pappas, N., King, P., & Wolf, A. P. (1995). Comparison of [1 lC]cocaine binding at sub-pharmacological and pharmacological doses in baboon brain. Journal of Nuclear Medicine, 36, 1289–1297.
Volkow, N. D., Wang, G.-J., Hitzemann, R., Fowler, J. S., Burr, G., & Wolf, A. P. (1995). Recovery of brain glucose metabolism in detoxified alcoholics. American Journal of Psychiatry, 151, 178–183.
Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Hitzemann, R., Gatley, S. J., Macgregor, R. R., & Wolf, A. P. (1996). Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology, 14, 159–168.
Wakasa, Y., Takada, K., & Yanagita, T. (1995). Reinforcing effect as a function of infusion speed in intravenous self-administration of nicotine in rhesus monkeys. Japanese Journal of Psychopharmacology, 15, 53–59.
Wall, S. C., Innis, R. B., & Rudnick, G. (1993). Binding of the cocaine analog 2b-carbomethoxy-3b-(4[’’-51]iodophenyl)tropane to serotonin and dopamine transporters: Different ionic requirements for substrate and 2(3-carbomethoxy-313-(4-r1]iodophenyl)tropane binding. Molecular Pharmacology, 43, 264–270.
Wang, G. J., Volkow, N. D., Logan, J., Fowler, J. S., Schlyer, D. J., MacGregor, R. R., Hitzemann, R. J., Gjedde, A., & Wolf, A. P. (1995). Serotonin 5-I1T2 receptor availability in chronic cocaine abusers. Life Sciences, 56, 299–303.
Wang, G. J., Volkow, N. D., Hitzemann, R. J., Wong, C., Angrist, B., Burr, G., Pascani, K., Pappas, N., Lu, A., Cooper, T., & Lieberman, J. A. (1997). Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. European Addiction Research, 3, 49–54.
White, E J., Hu, X.-T., & Henry, D. J. (1993). Electrophysiological effects of cocaine in the rat nucleus accumbens: Microiontophoretic studies. Journal of Pharmacology and Experimental Therapeutics. 166, 1075–1084.
White, S. R., Harris, G. C., Imel, K. M., & Wheaton, M. J. (1995). Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA) on glutamate-evoked firing of nucleus accumbens and caudate/putamen cells are enhanced following cocaine self-administration. Brain Research, 681, 167–176.
Wilkinson, P, VanDyke, C., Jatlow, P., Barash, P., & Byck, R. (1980). Intranasal and oral cocaine kinetics. Clinical Pharmacologic Therapeutics, 27, 386–394.
Wolf, M. E., & Jeziorski, M. (1993). Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Research, 613, 291–294.
Wolf, M. E., White, F. J., Nassar, R., Brooderson, R. J., & Khansa, M. R. (1993). Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. Journal of Pharmacology and Experimental Therapeutics, 264, 249–255.
Wolkin, A., Angrist, B., Wolf, A., Brodie, J., Wolkin, B., Jaeger, J., Cancro, R., & Rotrosen, J. (1987). Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology, 92, 241–252.
Wong, D. T., & Bymaster, F. P. (1978). An inhibitor of dopamine reuptake, LR5182, cis-3-(3,4-dichlorophenyl)-2-N,N-dimethy laminomethyl-bicyclo [2,2,2]octane, hydrochloride. Life Sciences, 23, 1041–1047.
Yu, D. W., Gatley, S. J., Wolf, A. P., MacGregor, R. R., Dewey, S. L., Fowler, J. S., & Schlyer, D. (1992). Synthesis of carbon-11 labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography. Journal of Medicinal Chemistry, 35, 2178–2183.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gatley, S.J., Gifford, A.N., Volkow, N.D., Fowler, J.S. (1998). Pharmacology of Cocaine. In: Tarter, R.E., Ammerman, R.T., Ott, P.J. (eds) Handbook of Substance Abuse. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2913-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2913-9_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3297-6
Online ISBN: 978-1-4757-2913-9
eBook Packages: Springer Book Archive